In metaplastic breast cancer, CRYAB was found to be highly expressed and associated with brain metastasis, and silencing the CRYAB gene using RNA interference technology significantly reduced tumor invasion and metastasis ability [7,8]. Here, CRYAB is linked to breast carcinoma.